AS

Afiya Suhail Shaikh

Active Director Director DIN 11407397
DIN 11407397 First appointment Dec 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Afiya Suhail Shaikh

Data last updated:

Afiya Suhail Shaikh is a Director at Sahil Centre For Stem Cell Research And Development (Scrd) Foundation (since 2025) and Director at Scrd Therapeutics Private Limited (since 2025). The companies operate in Biotechnology.

DIN 11407397
Primary Designation Director
Industry Biotechnology
First Appointment 03 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Dec 20252025Active
Scrd Therapeutics Private Limited U21001MH2025PTC461873
Director03 Dec 20252025Active

Directorship timeline

Open interactive timeline →
Sahil Centre For Stem Cell Research And Development (Scrd) Foundation
Scrd Therapeutics Private Limited
Premium access

Shareholding and investment profile for Afiya Suhail Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Afiya Suhail Shaikh

Afiya Suhail Shaikh currently holds 2 directorships: Sahil Centre For Stem Cell Research And Development (Scrd) Foundation (Director, since 23 Dec 2025); Scrd Therapeutics Private Limited (Director, since 03 Dec 2025).

Afiya Suhail Shaikh was first appointed on 03 Dec 2025 as Director at Scrd Therapeutics Private Limited.

The current boards of Afiya Suhail Shaikh's companies include Suhail Abdulrahman Shaikh (Sahil Centre For Stem Cell Research And Development (Scrd) Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available